Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Peruvian oncologists renew cervical screening calls, as local data show 30% cancer rate

This article was originally published in Clinica

Executive Summary

Almost a third of women screened for cervical cancer at a centre serving a Peruvian suburb were found to have the disease. So said the health ministry, citing an assessment of data from the first 1,000 women screened (by Pap smear) this year in the Lima Este area of the capital. Cancer experts involved in the programme are calling on all sexually-active women to come forward for testing "annually or at least once every three years". Women aged 30-49 years in Peru are being asked to undergo screening annually, "as a matter of course". Cervical cancer is the second-leading cause of death among Peruvian women.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041848

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel